These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1457860)

  • 41. How are European patients at risk of malignant arrhythmias or sudden cardiac death identified and informed about their risk profile: results of the European Heart Rhythm Association survey.
    Proclemer A; Bongiorni MG; Dagres N; Sciaraffia E; Todd D; Blomstrom-Lundqvist C;
    Europace; 2015 Jun; 17(6):994-8. PubMed ID: 26023178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical interventions in ischemic ventricular tachyarrhythmias--endocardial resection or implanted cardioverter/defibrillator.
    Fieguth HG; Trappe HJ; Wahlers T; Siclari F; Frank G; Borst HG
    Eur J Cardiothorac Surg; 1994; 8(8):400-3. PubMed ID: 7527231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
    Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia.
    Evonich RF; Maheshwari A; Gardiner JC; Khasnis A; Kantipudi S; Ip JH; Grimes D; Hayter G; Thakur RK
    J Interv Card Electrophysiol; 2004 Aug; 11(1):59-65. PubMed ID: 15273456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Devices for the management of ventricular arrhythmias in cardiac failure.
    Cooklin M
    Heart Fail Rev; 2002 Jul; 7(3):301-10. PubMed ID: 12215734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective analysis of patients undergoing one- or two-stage strategies for myocardial revascularization and implantable cardioverter defibrillator implantation.
    Pinski SL; Mick MJ; Arnold AZ; Golding L; McCarthy PM; Castle LW; Maloney JD; Trohman RG
    Pacing Clin Electrophysiol; 1991 Jul; 14(7):1138-47. PubMed ID: 1715551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the wearable cardioverter defibrillator in clinical practice.
    Chung MK
    Cardiol Clin; 2014 May; 32(2):253-70. PubMed ID: 24793801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.
    Akhtar M; Jazayeri M; Sra J; Tchou P; Rovang K; Blanck Z; Dhala A; Deshpande S; Axtell K
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 2):511-8. PubMed ID: 7681950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased risk of ventricular arrhythmias in survivors of out-of-hospital cardiac arrest with chronic total coronary occlusion.
    Yap SC; Sakhi R; Theuns DAMJ; Yasar YE; Bhagwandien RE; Diletti R; Zijlstra F; Szili-Torok T
    Heart Rhythm; 2018 Jan; 15(1):124-129. PubMed ID: 28917556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ICD implantation with and without combined myocardial revascularisation--incidence of ICD therapy and late survival.
    Brockes C; Rahn-Schönbeck M; Duru F; Candinas R; Seifert B; Turina M
    Thorac Cardiovasc Surg; 2002 Dec; 50(6):333-6. PubMed ID: 12457308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AICD treatment in 2004--state of the art.
    Budde T
    Eur J Med Res; 2006 Oct; 11(10):432-8. PubMed ID: 17107877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
    Barsheshet A; Goldenberg I; Moss AJ; Huang DT; Zareba W; McNitt S; Klein HU; Guetta V
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1237-42. PubMed ID: 21615813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Non-pharmacologic prevention of sudden cardiac death].
    Jurkovicová O; Cagán S
    Bratisl Lek Listy; 1997; 98(7-8):423-39. PubMed ID: 9471337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of microvolt T-wave alternans testing in scheduling implantable cardioverter-defibrillator placement for the primary prevention of sudden cardiac death in patients with left ventricular dysfunction.
    Daniłowicz-Szymanowicz L; Suchecka J; Zagożdżon P; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2015; 73(6):429-36. PubMed ID: 25371309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term surgical results in sudden death syndrome associated with cardiac dysfunction after myocardial infarction.
    Bolooki H; Horowitz MD; Interian A; Thurer RJ; Palatianos GM; DeMarchena EJ; Perryman RA; Myerburg RJ
    Ann Surg; 1992 Sep; 216(3):333-41; discussion 342-3. PubMed ID: 1417183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.